KBI BIOPHARMA H-1B Visa Sponsorship & Salary Data

The median H-1B salary at KBI BIOPHARMA is $91,000, based on 118 certified filings from FY 2020 to FY 2026. This is 24% lower than the national H-1B median salary of $120,000. Compensation at KBI BIOPHARMA reflects their market positioning, with entry-level roles starting around $77,251 and senior positions reaching $143,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at KBI BIOPHARMA range from $66,950 at the 10th percentile to $143,000 at the 90th percentile, showing a $76,050 spread across experience levels and roles. The 25th percentile is $77,251 and the 75th percentile is $114,000.

Yes, KBI BIOPHARMA actively sponsors H-1B visas in FY 2026. In the most recent fiscal year (FY 2026), KBI BIOPHARMA filed 11 H-1B labor condition applications with 10 certified and 1 denied, at a median salary of $104,000. Across FY 2020–2026, they have filed 123 total H-1B applications with 118 certified and a 1.6% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. KBI BIOPHARMA sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), KBI BIOPHARMA filed 11 H-1B applications, with 10 certified and 1 denied. Over 7 years of data, KBI BIOPHARMA has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

KBI BIOPHARMA's LCA (Labor Condition Application) denial rate is 1.6%, with 2 out of 123 applications denied across all years. This translates to a 98.4% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating KBI BIOPHARMA as a potential H-1B sponsor.

This is a good approval rate, comparable to industry averages. KBI BIOPHARMA demonstrates reliable H-1B sponsorship practices.

KBI BIOPHARMA sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 118 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles KBI BIOPHARMA most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at KBI BIOPHARMA:

The most frequently sponsored role is Research Scientist I with 18 filings at a median salary of $90,000. This is followed by Senior Research Associate (7 filings) and Validation Engineer II.

KBI BIOPHARMA's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where KBI BIOPHARMA sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top KBI BIOPHARMA H-1B locations:

The largest H-1B hub for KBI BIOPHARMA is Durham, NC with 95 filings at a median salary of $90,000. The highest-paying location is Prosper, TX at $137,000 median. Salaries range from $84,011 to $137,000 across office locations.

KBI BIOPHARMA's median H-1B salary has increased by +26% from FY 2020 ($82,400) to FY 2026 ($104,000). Tracking salary trends over time reveals how KBI BIOPHARMA adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at KBI BIOPHARMA.

Year-by-year breakdown:

• FY 2022: $90,000 (25 certified)
• FY 2023: $86,500 (14 certified)
• FY 2024: $115,000 (10 certified)
• FY 2025: $108,848 (26 certified)
• FY 2026: $104,000 (10 certified)

This 26% growth reflects strong compensation adjustments at KBI BIOPHARMA, keeping pace with market demands for H-1B talent.

KBI BIOPHARMA primarily files H-1B applications at Wage Level II, accounting for 37% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making KBI BIOPHARMA's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

KBI BIOPHARMA has a mix of entry-level (Level I) and experienced (Level II+) H-1B positions. This reflects a range of roles from junior to senior.

KBI BIOPHARMA's median H-1B salary of $91,000 is 24% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating KBI BIOPHARMA's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare KBI BIOPHARMA's offerings with similar companies in your field for a more accurate assessment.

KBI BIOPHARMA's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. KBI BIOPHARMA files 29% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 118 certified filings, KBI BIOPHARMA invests significantly in H-1B sponsorship. The company's 1.6% denial rate suggests solid H-1B processing practices.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.